文献速递消化道肿瘤与早癌消化内镜

一次性经鼻胶囊内镜用于巴雷特食管筛查的可接受性、准确性与安全性

Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-08-03

这项前瞻性多中心队列研究在3家转诊中心纳入200例同意参与者,178例(89%)完成EG Scan II与常规食管胃十二指肠镜(C-EGD)检查,巴雷特食管(BE)患病率为53%。EG Scan识别任何长度BE的灵敏度为0.90(95%CI 0.83-0.96)、特异度为0.91(95%CI 0.82-0.96),无严重不良事件,更多患者偏好EG Scan。

要点

  • EG Scan识别任何长度BE的灵敏度0.90(95%CI 0.83-0.96),特异度0.91(95%CI 0.82-0.96)。
  • EG Scan识别长段BE灵敏度0.95,短段BE灵敏度0.87。
  • 54.2%患者偏好EG Scan vs 16.7%偏好C-EGD(P<.001),VAS评分7.2 vs 6.4(P=.0004)。

核心结论

  • EG Scan安全,检测BE的灵敏度和特异度均高于90%,更多患者偏好EG Scan而非C-EGD。
  • 该设备或可作为基于诊所的工具用于筛查BE高危人群。

研究设计与样本

  • 前瞻性多中心队列研究,从3家转诊中心(美国1家、英国2家)纳入有和无BE的患者。
  • 200例同意参与者中178例(89%)完成两种检查,11%因无法插管鼻咽部致EG Scan失败。
  • 参与者平均年龄57.9岁,67%为男性,BE患病率53%。
  • 所有受试者同日接受两种检查,由设盲内镜医师操作。

主要发现

  • 54.2%患者偏好EG Scan vs 16.7%偏好C-EGD(P<.001)。
  • EG Scan的VAS评分7.2 vs C-EGD 6.4(P=.0004)。
  • 无严重不良事件发生。
  • EG Scan识别任何长度BE的灵敏度0.90(95%CI 0.83-0.96),特异度0.91(95%CI 0.82-0.96)。
  • EG Scan识别长段BE灵敏度0.95,短段BE灵敏度0.87。

临床怎么用

  • 原文结论认为该设备或可作为基于诊所的工具用于筛查BE高危人群。

局限性

  • 11%因无法插管鼻咽部致EG Scan失败。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Screening for Barrett's esophagus (BE) with conventional esophagogastroduodenoscopy (C-EGD) is expensive. We assessed the performance of a clinic-based, single use transnasal capsule endoscope (EG Scan II) for the detection of BE, compared to C-EGD as the reference standard. METHODS: We performed a prospective multicenter cohort study of patients with and without BE recruited from 3 referral centers (1 in the United States and 2 in the United Kingdom). Of 200 consenting participants, 178 (89%) completed both procedures (11% failed EG Scan due to the inability to intubate the nasopharynx). The mean age of participants was 57.9 years and 67% were male. The prevalence of BE was 53%. All subjects underwent the 2 procedures on the same day, performed by blinded endoscopists. Patients completed preference and validated tolerability (10-point visual analogue scale [VAS]) questionnaires within 14 days of the procedures. RESULTS: A higher proportion of patients preferred the EG Scan (54.2%) vs the C-EGD (16.7%) (P < .001) and the EG Scan had a higher VAS score (7.2) vs the C-EGD (6.4) (P = .0004). No serious adverse events occurred. The EG Scan identified any length BE with a sensitivity value of 0.90 (95% CI, 0.83-0.96) and a specificity value of 0.91 (95% CI, 0.82-0.96). The EG Scan identified long segment BE with a sensitivity value of 0.95 and short segment BE with a sensitivity values of 0.87. CONCLUSIONS: In a prospective study, we found the EG Scan to be safe and to detect BE with higher than 90% sensitivity and specificity. A higher proportion of patients preferred the EG Scan to C-EGD. This device might be used as a clinic-based tool to screen populations at risk for BE. ISRCTN registry identifier: 70595405; ClinicalTrials.gov no: NCT02066233.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Sami SS, Iyer PG, Pophali P, et al. Acceptability, Accuracy, and Safety of Disposable Transnasal Capsule Endoscopy for Barrett's Esophagus Screening. Clin Gastroenterol Hepatol. 2018. PMID: 30081223. doi:10.1016/j.cgh.2018.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。